PMID: 8942969Nov 26, 1996Paper

Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease

Proceedings of the National Academy of Sciences of the United States of America
A I Levey

Abstract

Cholinergic transmission at muscarinic acetylcholine receptors (mAChR) has been implicated in higher brain functions such as learning and memory, and loss of synapses may contribute to the symptoms of Alzheimer disease. A heterogeneous family of five genetically distinct mAChR subtypes differentially modulate a variety of intracellular signaling systems as well as the processing of key molecules involved in the pathology of the disease. Although many muscarinic effects have been identified in memory circuits, including a diversity of pre- and post-synaptic actions in hippocampus, the identities of the molecular subtypes responsible for any given function remain elusive. All five mAChR genes are expressed in hippocampus, and subtype-specific antibodies have enabled identification, quantification, and localization of the encoded proteins. The m1, m2, and m4 mAChR proteins are most abundant in forebrain regions and they have distinct cellular and subcellular localizations suggestive of various pre- and postsynaptic functions in cholinergic circuits. The subtypes are also differentially altered in postmortem brain samples from Alzheimer disease cases. Further understanding of the molecular pharmacology of failing synapses in Alzhei...Continue Reading

References

Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·V Dolezal, S Tucek
Nov 11, 1992·JAMA : the Journal of the American Medical Association·M FarlowJ Dolan-Ureno
Jan 1, 1990·Annals of the New York Academy of Sciences·M RaiteriP Paudice
Oct 1, 1990·Journal of Neurophysiology·S Williams, D Johnston
Jan 1, 1990·Progress in Brain Research·J V Halliwell
Jan 1, 1990·Annual Review of Pharmacology and Toxicology·E C HulmeN J Buckley
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D M WeinerM R Brann
Jan 1, 1987·Psychopharmacology·J J HaganC L Broekkamp
Nov 1, 1986·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·R DoucetteH Mersky
Mar 1, 1985·Archives of Neurology·A R DamasioN Kassell
Feb 1, 1974·Archives of Neurology·D A Drachman, J Leavitt
Jul 30, 1982·Science·R T BartusA S Lippa
Jun 1, 1993·Pharmacology & Therapeutics·M P Caulfield
Jan 1, 1993·Progress in Brain Research·K Krnjević

❮ Previous
Next ❯

Citations

Oct 13, 2001·Journal of Neuroscience Research·M Y CheongM W Jung
Nov 15, 2002·Journal of Biomedical Science·R Bonfante-CabarcasJ A Moreno-Yanes
Sep 6, 2002·Journal of Molecular Neuroscience : MN·William S Messer
Aug 20, 2009·Journal of Molecular Neuroscience : MN·Sofia Jürgensen, Sergio T Ferreira
Feb 19, 2004·Brain Research. Molecular Brain Research·Iskender TeberJoachim Kremerskothen
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Abraham Fisher
Mar 9, 1999·Life Sciences·F P BymasterA Fink-Jensen
Sep 21, 2000·Mechanisms of Ageing and Development·J A JosephB Shukitt-Hale
Feb 14, 2002·Mechanisms of Ageing and Development·Seyed Khosrow TayebatiDamiano Zaccheo
Mar 29, 2003·Brain Research. Brain Research Reviews·Joanna M KarasinskaBrian F O'Dowd
Sep 24, 1998·Trends in Pharmacological Sciences· Haddad el-B, J Rousell
Nov 14, 2002·Behavioural Brain Research·Santiago MonleónAndrés Parra
Feb 13, 2001·Neurobiology of Aging·J JosephM A Smith
Aug 1, 1997·Progress in Neurobiology·P KásaK Gulya
Feb 2, 2002·Free Radical Biology & Medicine·J A JosephJ Strain
Oct 28, 1998·Journal of Physiology, Paris·R M NitschH von der Kammer
Jan 21, 2012·Expert Reviews in Molecular Medicine·Aarti N Patel, Jack H Jhamandas
Jan 21, 2011·Nature Reviews. Neuroscience·Amantha Thathiah, Bart De Strooper
Sep 30, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christoph NissenMathias Berger
Oct 12, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mark J Williams, Bryon Adinoff
Jun 29, 2010·Molecular BioSystems·Gregory J DigbyP Jeffrey Conn
Sep 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Lei MaWilliam J Ray
Nov 3, 2010·The Journal of Biological Chemistry·Shaowu ChengWilliam Z Suo
Nov 25, 2005·Anesthesiology·Ralph Lydic, Helen A Baghdoyan
Oct 30, 1998·Fundamental & Clinical Pharmacology·J PavíaF Sanchez de la Cuesta

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.